Form 4 for HCA HCA Healthcare
Accepted 2023-11-15 00:00:00 ET · period of report 2023-11-13 · accession 0001209191-23-055408 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-15 | 2023-11-13 | HCA | Akdamar Erol R | Group Pres | F - Tax | $229.99 | -14.0K | 12.9K | -52% | -$3.21M |
| D | 2023-11-15 | 2023-11-13 | HCA | Akdamar Erol R | Group Pres | M - OptEx | $47.97 | +26.8K | 26.8K | New | +$1.29M |
| DM | 2023-11-15 | 2023-11-13 | HCA | Akdamar Erol R | Group Pres | M - OptEx | $0.00 | -26.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-13 | F | D | 13,951 | $229.99 | 12,874 | D | — | — | |
| 2 | Common | Common Stock | 2023-11-13 | M | A | 26,825 | $47.97 | 26,825 | D | — | — | |
| 3 | Derivative | Stock Appreciation Right | 2023-11-13 | M | D | 14,500 | $0.00 | 0 | D | $47.97 · — to 2024-02-05 | 14,500 Common Stock | (F1) The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. |
| 4 | Derivative | Stock Appreciation Right | 2023-11-13 | M | D | 12,325 | $0.00 | 0 | D | $47.97 · — to 2024-02-05 | 12,325 Common Stock | (F2) The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. |